These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3964530)

  • 1. Gastrointestinal side effects after intravenous erythromycin lactobionate.
    Downey KM; Chaput de Saintonge DM
    Br J Clin Pharmacol; 1986 Mar; 21(3):295-9. PubMed ID: 3964530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side-effects due to the intravenous infusion of erythromycin lactobionate.
    Putzi R; Blaser J; Lüthy R; Wehrli R; Siegenthaler W
    Infection; 1983; 11(3):161-3. PubMed ID: 6885176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of serum levels, venous irritation and gastrointestinal side-effects with intravenous erythromycin lactobionate in patients with bronchopulmonary infection.
    Marlin GE; Thompson PJ; Jenkins CR; Burgess KR; LaFranier DA
    Hum Toxicol; 1983 Oct; 2(4):593-605. PubMed ID: 6642516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intravenous erythromycin lactobionate.
    Parsons RL; David JA; Raymond K; Stamp SM
    J Int Med Res; 1980; 8 Suppl 2():15-23. PubMed ID: 6968696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal side effects of intravenous erythromycin: incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment.
    Bowler WA; Hostettler C; Samuelson D; Lavin BS; Oldfield EC
    Am J Med; 1992 Mar; 92(3):249-53. PubMed ID: 1546723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacokinetics of 1,000 mg erythromycin lactobionate i. v. in patients with respiratory tract infections (author's transl)].
    Sietzen W
    Infection; 1982; 10 Suppl 2():S99-101. PubMed ID: 7107025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous erythromycin lactobionate-induced severe nausea and vomiting.
    Seifert CF; Swaney RJ; Bellanger-McCleery RA
    DICP; 1989 Jan; 23(1):40-4. PubMed ID: 2655295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin for Gastric Emptying in Patients Undergoing General Anesthesia for Emergency Surgery: A Randomized Clinical Trial.
    Czarnetzki C; Elia N; Frossard JL; Giostra E; Spahr L; Waeber JL; Pavlovic G; Lysakowski C; Tramèr MR
    JAMA Surg; 2015 Aug; 150(8):730-7. PubMed ID: 26083537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentration/time curve of erythromycin after a 12-hour intravenous infusion of erythromycin lactobionate in man.
    Parsons RL; David J; Paddock GM; Stamp ST
    Postgrad Med J; 1978 Feb; 54(628):68-71. PubMed ID: 345253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous erythromycin lactobionate in respiratory infections.
    Di Sciacca A; Durante F; Cucchiara G; Ingrassia A; Mira G; Mannone F; Di Piazza RM; Frontini A; Barbagallo Sangiorgi G
    J Int Med Res; 1987; 15(4):245-50. PubMed ID: 3653502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
    Shanson DC; Tidbury P; McNabb WR; Tadayon M
    J Antimicrob Chemother; 1984 Aug; 14(2):157-63. PubMed ID: 6334070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.
    Richards RD; Davenport K; McCallum RW
    Am J Gastroenterol; 1993 Feb; 88(2):203-7. PubMed ID: 8424421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of preoperative oral erythromycin, erythromycin-ranitidine, and ranitidine-metoclopramide on gastric fluid pH and volume.
    Bala I; Prasad K; Bhukal I; Nakra D; Pratap M
    J Clin Anesth; 2008 Feb; 20(1):30-4. PubMed ID: 18346606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial.
    Pateron D; Vicaut E; Debuc E; Sahraoui K; Carbonell N; Bobbia X; Thabut D; Adnet F; Nahon P; Amathieu R; Aout M; Javaud N; Ray P; Trinchet JC;
    Ann Emerg Med; 2011 Jun; 57(6):582-9. PubMed ID: 21333385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of erythromycin after parenteral administration.
    Chelvan P; Hamilton-Miller JM; Brumfitt W
    Br J Clin Pharmacol; 1979 Sep; 8(3):233-5. PubMed ID: 497089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacodynamics of erythromycin lactobionate during tonsillectomy in children].
    Leuthardt R; Trümpi B; Morger R
    Schweiz Med Wochenschr; 1989 Oct; 119(40):1372-4. PubMed ID: 2799345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin lactobionate: pharmacokinetics and uterine tissue levels.
    Segui A; Milon D; Cormier M; Lepesant G
    Eur J Drug Metab Pharmacokinet; 1987; 12(3):153-60. PubMed ID: 3436337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.
    Fiorucci S; Distrutti E; Gerli R; Morelli A
    Am J Gastroenterol; 1994 Apr; 89(4):550-5. PubMed ID: 8147358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers.
    Choi MG; Camilleri M; Burton DD; Johnson S; Edmonds A
    J Pharmacol Exp Ther; 1998 Apr; 285(1):37-40. PubMed ID: 9535992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects.
    Edelbroek MA; Horowitz M; Wishart JM; Akkermans LM
    J Nucl Med; 1993 Apr; 34(4):582-8. PubMed ID: 8455074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.